HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Calvin Klein Unleashes Truth In Fragrance

This article was originally published in The Rose Sheet

Executive Summary

Truth Calvin Klein women's scent is anchored in two recent fragrance trends: customization and sensuality. Slated to bow in August, the "lush, sensual" scent brings a "new olfactive family" to the fragrance market compared to traditional floral and oriental scents, Calvin Klein Cosmetics said.

You may also be interested in...



Calvin Klein Truth Mass Distribution Challenged In Lawsuit

Revelations Perfume and Cosmetics is seeking to prohibit the sale of Calvin Klein Truth men's and women's fragrances in the mass market in a lawsuit filed against Calvin Klein Cosmetics, owned by Unilever, and Calvin Klein Trademark Trust Sept. 24 in Manhattan state court

Calvin Klein Truth Mass Distribution Challenged In Lawsuit

Revelations Perfume and Cosmetics is seeking to prohibit the sale of Calvin Klein Truth men's and women's fragrances in the mass market in a lawsuit filed against Calvin Klein Cosmetics, owned by Unilever, and Calvin Klein Trademark Trust Sept. 24 in Manhattan state court

Calvin Klein To Share Truth With Men Via 3 Mil. Samples

Calvin Klein Cosmetics will back the June launch of Truth Calvin Klein Men with a $3 mil.-$4 mil. promotional budget that will include print ads and more than 3 mil. edt vial-on-card samples, licensee Unilever Cosmetics International said

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007989

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel